Human serum/plasma lipoprotein analysis by NMR: Application to the study of diabetic dyslipidemia

Progress in Nuclear Magnetic Resonance Spectroscopy

Volumn 70, Issue , 2013, Pages 1-24

  Mallol, Roger ^a,b   Rodriguez, Miguel Angel ^b,c   Brezmes, Jesus ^a,b,c   Masana, Lluis ^c,d   Correig, Xavier ^a,b,c  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Diabetic dyslipidemia; Lipoprotein analysis; NMR diffusion; NMR spectroscopy

Indexed keywords

BODY FLUIDS; DIFFUSION; LIPIDS; LIPOPROTEINS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

CALIBRATION AND VALIDATIONS; DYSLIPIDEMIAS; LIPOPROTEIN FRACTION; METABOLIC DISEASE; NMR DIFFUSION; ULTRACENTRIFUGATION; VISCOSITY PARAMETERS; WEALTH OF INFORMATION;

SPECTRUM ANALYSIS;

EID: 84875731156     PISSN: 00796565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnmrs.2012.09.001     Document Type: Review

References (168)

1. 13C NMR spectroscopy of human blood plasma Analytical Chemistry 67 1995 793 811
2. P. Soininen, A.J. Kangas, P. Wurtz, T. Tukiainen, T. Tynkkynen, R. Laatikainen, M.R. Jarvelin, M. Kahonen, T. Lehtimaki, J. Viikari, O.T. Raitakari, M.J. Savolainen, and M. Ala-Korpela High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism Analyst 134 2009 1781 1785
3. J.M. Steim, O.J. Edner, and F.G. Bargoot Structure of human serum lipoproteins: nuclear magnetic resonance supports a micellar model Science 162 1968 909 911
4. M. Petersen, M. Dyrby, S. Toubro, S.B. Engelsen, L. Norgaard, H.T. Pedersen, and J. Dyerberg Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models Clinical Chemistry 51 2005 1457 1461 (Pubitemid 41060878)
5. NMR LipoProfile test, LipoScience Inc, 2011. .
6. E.J. Jeyarajah, W.C. Cromwell, and J.D. Otvos Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy Clinics in Laboratory Medicine 26 2006 847 870 (Pubitemid 44716510)
7. 13C nuclear magnetic resonance studies of human serum low density lipoproteins Biochemistry 15 1976 4151 4157
8. J.K. Nicholson, M.P. O'Flynn, P.J. Sadler, A.F. Macleod, S.M. Juul, and P.H. Sonksen Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects Biochemistry Journal 217 1984 365 375 (Pubitemid 14178967)
9. S.S. Soedamah-Muthu, Y.F. Chang, J. Otvos, R.W. Evans, and T.J. Orchard Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study Diabetologia 46 2003 674 682 (Pubitemid 36808187)
10. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death Molecular Systems Biology 4 2008 167
11. R.L. Seip, J. Otvos, C. Bilbie, G.J. Tsongalis, M. Miles, R. Zoeller, P. Visich, P. Gordon, T.J. Angelopoulos, L. Pescatello, N. Moyna, and P.D. Thompson The effect of apolipoprotein E genotype on serum lipoprotein particle response to exercise Atherosclerosis 188 2006 126 133 (Pubitemid 44142525)
12. G.C. Burdge, J. Powell, T. Dadd, D. Talbot, J. Civil, and P.C. Calder Acute consumption of fish oil improves postprandial VLDL profiles in healthy men aged 50-65 years British Journal of Nutrition 102 2009 160 165
13. N. Jiang, X. Yan, W. Zhou, Q. Zhang, H. Chen, Y. Zhang, and X. Zhang NMR-based metabonomic investigations into the metabolic profile of the senescence-accelerated mouse Journal of Proteome Research 7 2008 3678 3686
14. H.H. Yu, G.S. Ginsburg, M.L. O'Toole, J.D. Otvos, P.S. Douglas, and N. Rifai Acute changes in serum lipids and lipoprotein subclasses in triathletes as assessed by proton nuclear magnetic resonance spectroscopy Arteriosclerosis Thrombosis and Vascular Biology 19 1999 1945 1949 (Pubitemid 29379926)
15. J.D. Otvos, I. Shalaurova, D.S. Freedman, and R.S. Rosenson Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial Atherosclerosis 160 2002 41 48 (Pubitemid 34082715)
16. M.P. Dube, J.W. Wu, J.A. Aberg, M.A. Deeg, B.L. Alston-Smith, M.E. McGovern, D. Lee, S.L. Shriver, A.I. Martinez, M. Greenwald, and J.H. Stein Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148 Antiviral Therapy 11 2006 1081 1089 (Pubitemid 44955184)
17. 1H NMR-based metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals Journal of Pharmaceutical and Biomedical Analysis 41 2006 1442 1446 (Pubitemid 43775905)
18. S.A. Riddler, X.H. Li, J. Otvos, W. Post, F. Palella, L. Kingsley, B. Visscher, L.P. Jacobson, and A.R. Sharrett Antiretroviral therapy is associated with an atherogenic lipoprotein phenotype among HIV-1-infected men in the multicenter AIDS cohort study JAIDS-Journal of Acquired Immune Deficiency Syndromes 48 2008 281 288
19. D.S. Moin, and A. Rohatgi Clinical applications of advanced lipoprotein testing in diabetes mellitus Clinical Lipidology 6 2011 371 387
20. H.R. Superko Advanced lipoprotein testing and subfractionation are clinically useful Circulation 119 2009 2383 2395
21. S. Mora Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use Circulation 119 2009 2396 2404
22. M. Inouye, J. Kettunen, P. Soininen, K. Silander, S. Ripatti, L.S. Kumpula, E. Hämäläinen, P. Jousilahti, A.J. Kangas, S. Männistö, M.J. Savolainen, A. Jula, J. Leiviskä, A. Palotie, V. Salomaa, M. Perola, M. Ala-Korpela, and L. Peltonen Metabonomic, transcriptomic, and genomic variation of a population cohort Molecular Systems Biology 6 2010
23. P. Würtz, P. Soininen, A.J. Kangas, V.P. Mäkinen, P.H. Groop, M.J. Savolainen, M. Juonala, J.S. Viikari, M. Kähönen, T. Lehtimäki, O.T. Raitakari, and M. Ala-Korpela Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis Molecular BioSystems 7 2011 385 393
24. B.E. Haas, D. Weissglas-Volkov, C.A. Aguilar-Salinas, E. Nikkola, L. Vergnes, I. Cruz-Bautista, L. Riba, A. Stancakova, J. Kuusisto, P. Soininen, A.J. Kangas, M. Ala-Korpela, T. Tusie-Luna, M. Laakso, and P. Pajukanta Evidence of how rs7575840 influences apolipoprotein B-containing lipid particles Arteriosclerosis, Thrombosis, and Vascular Biology 31 2011 1201 1207
25. F. Huber, W. Kremer, H.R. Kalbitzer, Determination of Lipoprotein Classes in Body Fluids Comprises Analyzing NMR Spectra of a Plasma or Serum Sample and Measuring Under Different Measuring Conditions; and Determining the Different Effects of These Measuring Conditions, UNIV REGENSBURG (UYRE-Non-standard) LIPOFIT ANALYTIC GMBH (LIPO-Non-standard).
26. 1H NMR-determined diffusion coefficients to characterize lipoprotein fractions in human blood plasma Magnetic Resonance in Chemistry 40 2002 S83-S88
27. H.N. Ginsberg Lipoprotein physiology Endocrinology and Metabolism Clinics of North America 27 1998 503 519 (Pubitemid 28446945)
28. P.B. Duell, D.R. Illingworth, and W.E. Connor Endocrinology and Metabolism fourth ed. 2001 McGraw-Hill New York
29. R.J. Havel, H.A. Eder, and J.H. Bragdon Distribution and chemical composition of ultracentrifugally separated lipoproteins in heman serum Journal of Clinical Investigation 34 1955 1345 1353
30. M. Hersberger, and A. Von Eckardstein Low high-density lipoprotein cholesterol: Physiological background, clinical importance and drug treatment Drugs 63 2003 1907 1945 (Pubitemid 37108401)
31. M.R. Taskinen Diabetic dyslipidemia Atherosclerosis Supplements 3 2002 47 51
32. R.M. Krauss Lipids and lipoproteins in patients with type 2 diabetes Diabetes Care 27 2004 1496 1504 (Pubitemid 38680002)
33. I.J. Goldberg Clinical review 124-diabetic dyslipidemia: causes and consequences Journal of Clinical Endocrinology and Metabolism 86 2001 965 971 (Pubitemid 32322966)
34. T.J. Chahil, and H.N. Ginsberg Diabetic dyslipidemia Endocrinology and Metabolism Clinics of North America 35 2006 491-+
35. B.V. Howard Insulin resistance and lipid metabolism American Journal of Cardiology 84 1999 28J-32J
36. H.N. Ginsberg, Y.L. Zhang, and A. Hernandez-Ono Regulation of plasma triglycerides in insulin resistance and diabetes Archives of Medical Research 36 2005 232 240 (Pubitemid 40755136)
37. B.S. Horowitz, I.J. Goldberg, J. Merab, T.M. Vanni, R. Ramakrishnan, and H.N. Ginsberg Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low-levels of high-density-lipoprotein cholesterol Journal of Clinical Investigation 91 1993 1743 1752 (Pubitemid 23127380)
38. D.P. Mikhailidis, M. Elisaf, M. Rizzo, K. Berneis, B. Griffin, A. Zambon, V. Athyros, J. de Graaf, W. Marz, K.G. Parhofer, G.B. Rini, G.A. Spinas, G.H. Tomkin, A.D. Tselepis, A.S. Wierzbicki, K. Winkler, M. Florentin, and E. Liberopoulos European panel on low density lipoprotein (LDL) subclasses: a statement on the pathophysiology Atherogenicity and Clinical Significance of LDL Subclasses, Current Vascular Pharmacology 9 2011 533 571
39. S.M. Grundy, R. Pasternak, P. Greenland, S. Smith, and V. Fuster Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations-a statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 100 1999 1481 1492 (Pubitemid 29451714)
40. P.W.F. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847 (Pubitemid 28213628)
41. N.J. Morrish, S.L. Wang, L.K. Stevens, J.H. Fuller, H. Keen, and W.H.O.M.S. Grp Mortality and causes of death in the WHO multinational study of vascular disease in diabetes Diabetologia 44 2001 S14-S21
42. P. Zimmet, K. Alberti, and J. Shaw Global and societal implications of the diabetes epidemic Nature 414 2001 782 787 (Pubitemid 34000780)
43. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge Clinical Chemistry 18 1972 499-&
44. R.M. Krauss, and D.J. Burke Identification of multipel subclasses of plasma low-density-lipoproteins in normal humans Journal of Lipid Research 23 1982 97 104 (Pubitemid 12112617)
45. M.H. Davidson, C.M. Ballantyne, T.A. Jacobson, V.A. Bittner, L.T. Braun, A.S. Brown, W.V. Brown, W.C. Cromwell, R.B. Goldberg, J.M. McKenney, A.T. Remaley, A.D. Sniderman, P.P. Toth, S. Tsimikas, P.E. Ziajka, K.C. Maki, and M.R. Dicklin Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists Journal of Clinical Lipidology 5 2011 338 367
46. K.R. Feingold, C. Grunfeld, M. Pang, W. Doerrler, and R.M. Krauss LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes Arteriosclerosis and Thrombosis 12 1992 1496 1502
47. R.S. Rosenson, H.B. Brewer, M.J. Chapman, S. Fazio, M.M. Hussain, A. Kontush, R.M. Krauss, J.D. Otvos, A.T. Remaley, and E.J. Schaefer HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events Clinical Chemistry 57 2011 392 410
48. W. Ensign, N. Hill, and C.B. Heward Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics Clinical Chemistry 52 2006 1722 1727 (Pubitemid 44330706)
49. M. Chung, A.H. Lichtenstein, S. Ip, J. Lau, and E.M. Balk Comparability of methods for LDL subfraction determination: a systematic review Atherosclerosis 205 2009 342 348
50. R.M. Krauss Lipoprotein subfractions and cardiovascular disease risk Current Opinion in Lipidology 21 2010 305 311
51. K.R. Kulkarni, D.W. Garber, S.M. Marcovina, and J.P. Segrest Quantification of cholesterol in all lipoprotein classes by the VAP-II method Journal of Lipid Research 35 1994 159 168 (Pubitemid 24028002)
52. G.R. Warnick, J.R. McNamara, C.N. Boggess, F. Clendenen, P.T. Williams, and C.C. Landolt Polyacrylamide gradient gel electrophoresis of lipoprotein subclasses Clinics in Laboratory Medicine 26 2006 803-+
53. T. Sakurai, S. Trirongjitmoah, Y. Nishibata, T. Namita, M. Tsuji, S.P. Hui, S. Jin, K. Shimizu, and H. Chiba Measurement of lipoprotein particle sizes using dynamic light scattering Annals of Clinical Biochemistry 47 2010 476 481
54. M. Okazaki, S. Usui, A. Fukui, I. Kubota, and H. Tomoike Component analysis of HPLC profiles of unique lipoprotein subclass cholesterols for detection of coronary artery disease Clinical Chemistry 52 2006 2049 2053 (Pubitemid 44658206)
55. M.P. Caulfield, S. Li, G. Lee, P.J. Blanche, W.A. Salarneh, W.H. Benner, R.E. Reitz, and R.M. Krauss Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis Clinical Chemistry 54 2008 1307 1316
56. R. Mallol, M. Rodríguez, M. Heras, M. Vinaixa, N. Plana, L. Masana, G. Morris, and X. Correig Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy Analytical and Bioanalytical Chemistry 402 2012 2407 2415
57. O. Beckonert, H.C. Keun, T.M. Ebbels, J. Bundy, E. Holmes, J.C. Lindon, and J.K. Nicholson Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts Nature Protocols 2 2007 2692 2703
58. 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects Journal of Pharmaceutical and Biomedical Analysis 33 2003 1103 1115 (Pubitemid 37501013)
59. K.M. Brindle, F.F. Brown, I.D. Campbell, C. Grathwohl, and P.W. Kuchel Application of spin-echo nuclear magnetic resonance to whole-cell systems. Membrane transport Biochemistry Journal 180 1979 37 44
60. 1H NMR studies of vertebrate blood and plasma Biochemical Journal 211 1983 605 615 (Pubitemid 13103190)
61. D.L. Rabenstein, K.K. Millis, and E.J. Strauss Proton NMR spectroscopy of human blood plasma and red blood cells Analytical Chemistry 60 1988 1380A-1391A
62. I. Björk, and U. Lindahl Mechanism of the anticoagulant action of heparin Molecular and Cellular Biochemistry 48 1982 161 182 (Pubitemid 13224668)
63. R.H. Barton, D. Waterman, F.W. Bonner, E. Holmes, R. Clarke, J.K. Nicholson, and J.C. Lindon The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies Molecular BioSystems 6 2010 215 224
64. J.D. Otvos, E.J. Jeyarajah, and D.W. Bennett Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy Clinical Chemistry 37 1991 377 386 (Pubitemid 21892658)
65. J.D. Bell, J.C. Brown, and P.J. Sadler NMR studies of body fluids NMR in Biomedicine 2 1989 246 256
66. M. Kriat, S. Confort-Gouny, J. Vion-Dury, M. Sciaky, P. Viout, and P.J. Cozzone Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy. A comparative study of the use of formate and TSP as concentration standards NMR in Biomedicine 5 1992 179 184
67. R.A. de Graaf, and K.L. Behar Quantitative 1H NMR spectroscopy of blood plasma metabolites Analytical Chemistry 75 2003 2100 2104 (Pubitemid 36542350)
68. V. Silvestre, S. Goupry, M. Trierweiler, R. Robins, and S. Akoka Determination of substrate and product concentrations in lactic acid bacterial fermentations by proton NMR using the ERETIC method Analytical Chemistry 73 2001 1862 1868 (Pubitemid 32862454)
69. R.D. Farrant, J.C. Hollerton, S.M. Lynn, S. Provera, P.J. Sidebottom, and R.J. Upton NMR quantification using an artificial signal Magnetic Resonance in Chemistry 48 2010 753 762
70. P.S.C. Wu, and G. Otting Rapid pulse length determination in high-resolution NMR Journal of Magnetic Resonance 176 2005 115 119 (Pubitemid 41162482)
71. A. Ross, G. Schlotterbeck, F. Dieterle, H. Senn, NMR spectroscopy techniques for application to metabonomics, in: John C. Lindon, Jeremy K. Nicholson, Elaine Holmes (Eds.), The Handbook of Metabonomics and Metabolomics, Elsevier Science B.V., Amsterdam, 2007, pp. 55-112 (Chapter 3).
72. H.Y. Carr, and E.M. Purcell Effects of diffusion on free precession in nuclear magnetic resonance experiments Physical Review 94 1954 630 638
73. S. Meiboom, and D. Gill Modified spin-echo method for measuring nuclear relaxation times Review of Scientific Instruments 29 1958 688 691
74. 1H NMR spectroscopy of biological fluids Analytical Chemistry 68 1996 3370 3376
75. H. Tang, Y. Wang, J.K. Nicholson, and J.C. Lindon Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma Analytical Biochemistry 325 2004 260 272 (Pubitemid 38134363)
76. E. Saude, C. Slupsky, and B. Sykes Optimization of NMR analysis of biological fluids for quantitative accuracy Metabolomics: Official journal of the Metabolomic Society 2 2006 113 123 (Pubitemid 44473570)
77. R. Novoa-Carballal, E. Fernandez-Megia, C. Jimenez, and R. Riguera NMR methods for unravelling the spectra of complex mixtures Natural Products Reports 28 2011 78 98
78. 1H NMR metabonomics as a prognostic and diagnostic tool Expert Review of Molecular Diagnostics 7 2007 761 773 (Pubitemid 350171839)
79. M. Ala-Korpela Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics Clinical Chemistry and Laboratory Medicine: CCLM/FESCC 46 2008 27 42
80. J. Lounila, M. Alakorpela, J. Jokisaari, M.J. Savolainen, and Y.A. Kesaniemi Effects of orientational order and particle-size on the NMR line positions of lipoproteins Physical Review Letters 72 1994 4049 4052 (Pubitemid 24975582)
81. J. Otvos, E. Jeyarajah, D. Bennett, and R. Krauss Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement Clinical Chemistry 38 1992 1632 1638
82. 1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma Journal of Lipid Research 35 1994 2292 2304
83. A. van den Boogaart, M. Ala-Korpela, J. Jokisaari, and J.R. Griffiths Time and frequency domain analysis of NMR data compared: an application to 1D 1H spectra of lipoproteins Magnetic Resonance in Medicine 31 1994 347 358 (Pubitemid 24108263)
84. 1H NMR metabonomics of plasma lipoprotein subclasses: elucidation of metabolic clustering by self-organising maps NMR in Biomedicine 20 2007 658 672 (Pubitemid 350120246)
85. 1H NMR metabonomic data BMC Bioinformatics 8 Suppl. 2 2007 S8
86. M. Petersen, M. Dyrby, S. Toubro, S.B. Engelsen, L. Norgaard, H.T. Pedersen, and J. Dyerberg Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models Clinical Chemistry 51 2005 1457 1461 (Pubitemid 41060878)
87. B. Antalek Using pulsed gradient spin echo NMR for chemical mixture analysis: how to obtain optimum results Concepts in Magnetic Resonance 14 2002 225 258
88. W.S. Price Pulsed-field gradient nuclear magnetic resonance as a tool for studying translational diffusion: Part 1. Basic theory Concepts in Magnetic Resonance 9 1997 299 336 (Pubitemid 127116750)
89. W.S. Price Pulsed-field gradient nuclear magnetic resonance as a tool for studying translational diffusion: Part II. Experimental aspects Concepts in Magnetic Resonance 10 1998 197 237 (Pubitemid 128642643)
90. G.H. Sorland, and D. Aksnes Artefacts and pitfalls in diffusion measurements by NMR Magnetic Resonance in Chemistry 40 2002 S139-S146
91. C.S. Johnson Jr. Diffusion ordered nuclear magnetic resonance spectroscopy: principles and applications Progress in Nuclear Magnetic Resonance Spectroscopy 34 1999 203 256 (Pubitemid 129595218)
92. E.O. Stejskal, and J.E. Tanner Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient The Journal of Chemical Physics 42 1965 288 292
93. T.M. Squires, and T.G. Mason Fluid mechanics of microrheology Annual Review of Fluid Mechanics 42 2010 413 438
94. 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependent Atherosclerosis 190 2007 352 358 (Pubitemid 46074051)
95. 1H NMR PFG measurements Physical Chemistry Chemical Physics 2 2000 4740 4742
96. J.E. Tanner Use of the stimulated echo in NMR diffusion studies The Journal of Chemical Physics 52 1970 2523 2526
97. S.J. Gibbs, K.F. Morris, and C.S. Johnson Jr. Design and implementation of a shielded gradient coil for PFG NMR diffusion and flow studies Journal of Magnetic Resonance 94 1991 1969 165 169
98. O. Söderman, and P. Stilbs NMR studies of complex surfactant systems Progress in Nuclear Magnetic Resonance Spectroscopy 26 1994 445 482 Part 5 (Pubitemid 124003832)
99. S.J. Gibbs, and C.S. Johnson Jr. A PFG NMR experiment for accurate diffusion and flow studies in the presence of eddy currents Journal of Magnetic Resonance 93 1991 1969 395 402
100. D.H. Wu, A.D. Chen, and C.S. Johnson An improved diffusion-ordered spectroscopy experiment incorporating bipolar-gradient pulses Journal of Magnetic Resonance, Series A 115 1995 260 264
101. L.M. Smith, A.D. Maher, O. Cloarec, M. Rantalainen, H. Tang, P. Elliott, J. Stamler, J.C. Lindon, E. Holmes, and J.K. Nicholson Statistical correlation and projection methods for improved information recovery from diffusion-edited NMR spectra of biological samples Analytical Chemistry 79 2007 5682 5689 (Pubitemid 47229815)
102. K. Hayamizu, and W.S. Price A new type of sample tube for reducing convection effects in PGSE-NMR measurements of self-diffusion coefficients of liquid samples Journal of Magnetic Resonance 167 2004 328 333
103. 1H NMR spectroscopy data for the characterisation of human plasma lipoproteins Metabolomics 7 2011 572 582
104. N. Esturau, F. Sánchez-Ferrando, J.A. Gavin, C. Roumestand, M.-A. Delsuc, and T. Parella The use of sample rotation for minimizing convection effects in self-diffusion NMR measurements Journal of Magnetic Resonance 153 2001 48 55
105. A. Jerschow, and N. Müller Suppression of convection artifacts in stimulated-echo diffusion experiments. Double-stimulated-echo experiments Journal of Magnetic Resonance 125 1997 372 375 (Pubitemid 127451901)
106. J.C. Cobas, P. Groves, M. Martin-Pastor, and A.D. Capua New applications, processing methods and pulse sequences using diffusion NMR Current Analytical Chemistry 1 2005 289 305
107. M. Dyrby, M. Petersen, A.K. Whittaker, L. Lambert, L. Norgaard, R. Bro, and S.B. Engelsen Analysis of lipoproteins using 2D diffusion-edited NMR spectroscopy and multi-way chemometrics Analytica Chimica Acta 531 2005 209 216 (Pubitemid 40255156)
108. M. AlaKorpela, in: H-1 NMR Spectroscopy of Human Blood Plasma, 1995, pp. 475-554.
109. J. Higinbotham, I. Marshall, NMR lineshapes and lineshape fitting procedures, in: Annual Reports on NMR Spectroscopy, vol. 43, 2001, pp. 59-120. (Pubitemid 33804612)
110. J.D. Otvos, E.J. Jeyarajah, and D.W. Bennett Quantification of plasma-lipoproteins by proton nuclear-magnetic-resonance spectroscopy Clinical Chemistry 37 1991 377 386 (Pubitemid 21892658)
111. J.D. Otvos, E.J. Jeyarajah, D.W. Bennett, and R.M. Krauss Development of a proton nuclear-magnetic-resonance spectroscopic method for determining plasma-lipoprotein concentrations and subspecies distributions from a single Rapid Measurement, Clinical Chemistry 38 1992 1632 1638
112. F. Hatch, and R. Lees Practical method for plasma lipoprotein analysis Advances in Lipid Research 6 1968 1 68
113. Caslake MJ, Packard CJ. The Use of Ultracentrifugation for the Separation of Lipoproteins, second ed., AACC Press, Washington, DC 2000.
114. B. Kaess, M. Fischer, A. Baessler, K. Stark, F. Huber, W. Kremer, H.R. Kalbitzer, H. Schunkert, G. Riegger, and C. Hengstenberg The lipoprotein subfraction profile: heritability and identification of quantitative trait loci Journal of Lipid Research 49 2008 715 723
115. L.L. Rudel, C.A. Marzetta, and F.L. Johnson Separation and analysis of lipoproteins by gel filtration Methods in Enzymology 129 1986 45 57 (Pubitemid 16055940)
116. A.V. Nichols, R.M. Krauss, and T.A. Musliner Nondenaturing polyacrylamide gradient gel electrophoresis Methods in Enzymology 128 1986 417 431 (Pubitemid 16100908)
117. D.L. Rainwater, P.H. Moore Jr., W.R. Shelledy, T.D. Dyer, and S.H. Slifer Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins Journal of Lipid Research 38 1997 1261 1266 (Pubitemid 27281820)
118. D.L. Rainwater, P.H. Moore Jr., and I.O. Gamboa Improved method for making nondenaturing composite gradient gels for the electrophoretic separation of lipoproteins Journal of Lipid Research 45 2004 773 775 (Pubitemid 38405685)
119. D.L. Rainwater Lipoprotein correlates of LDL particle size Atherosclerosis 148 2000 151 158
120. 1H NMR Method for Lipoprotein Quantification and Coronary Heart Disease Risk Assessment, Degree of Doctor of Philosophy, CHEMISTRY, Graduale Faculty of North Carolina State University, 2004.
121. J.D. Otvos, Method, Systems and Computer Programs for Assessing CHD Risk Using Adjusted LDL Particle Number Measurements, US Patent Application Number: US 7,790,465 B2, 2010.
122. J.D. Otvos, E.J. Jeyarajah, and W.C. Cromwell Measurement issues related to lipoprotein heterogeneity American Journal of Cardiology 90 2002 22I-29I
123. T.M. Forte, and R.W. Nordhausen Electron microscopy of negatively stained lipoproteins Methods in Enzymology 128 1986 442 457 (Pubitemid 16100910)
124. H. Campos, J.J. Genest, E. Blijlevens, J.R. McNamara, J.L. Jenner, J.M. Ordovas, P.W.F. Wilson, and E.J. Schaefer LDL particle-size and coronary artery disease Arteriosclerosis and Thrombosis 12 1992 187 195
125. M. Alakorpela, A. Korhonen, J. Keisala, S. Horkko, P. Korpi, L.P. Ingman, J. Jokisaari, M.J. Savolainen, and Y.A. Kesaniemi H-1 NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma Journal of Lipid Research 35 1994 2292 2304
126. M. Alakorpela, Y. Hiltunen, J. Jokisaari, S. Eskelinen, K. Kiviniitty, M.J. Savolainen, and Y.A. Kesaniemi A comparative-study of H-1-NMR lineshape fitting analyses and biochemical lipid analyses of the lipoprotein fractions VLDL, LDL and HDL, and total human blood-plasma NMR in Biomedicine 6 1993 225 233
127. I. Surakka, A. Isaacs, L.C. Karssen, P.P.P. Laurila, R.P.S. Middelberg, E. Tikkanen, J.S. Ried, C. Lamina, M. Mangino, W. Igl, J.J. Hottenga, V. Lagou, P. van der Harst, I. Leach, T. Esko, Z. Kutalik, N.W. Wainwright, M.V. Struchalin, A.P. Sarin, A.J. Kangas, J.S. Viikari, M. Perola, T. Rantanen, A.K. Petersen, P. Soininen, Å. Johansson, N. Soranzo, A.C. Heath, T. Papamarkou, I. Prokopenko, A. Tönjes, F. Kronenberg, A. Döring, F. Rivadeneira, G.W. Montgomery, J.B. Whitfield, M. Kähönen, T. Lehtimäki, N.B. Freimer, G. Willemsen, E.J.C. de Geus, A. Palotie, M.S. Sandhu, D.M. Waterworth, A. Metspalu, M. Stumvoll, A.G. Uitterlinden, A. Jula, G. Navis, C. Wijmenga, B.H.R. Wolffenbuttel, M.R. Taskinen, M. Ala-Korpela, J. Kaprio, K.O. Kyvik, D.I. Boomsma, N.L. Pedersen, U. Gyllensten, J.F. Wilson, I. Rudan, H. Campbell, P.P. Pramstaller, T.D. Spector, J.C.M. Witteman, J.G. Eriksson, V. Salomaa, B.A. Oostra, O.T. Raitakari, H.E. Wichmann, C. Gieger, M.R. Järvelin, N.G. Martin, A. Hofman, M.I. McCarthy, L. Peltonen, C.M. van Duijn, Y.S. Aulchenko, S. Ripatti, A genome-wide screen for interactions reveals a new locus on 4p15 modifying the effect of waist-to-hip ratio on total cholesterol, PLoS Genetics 7 (2011).
128. M. Ala-Korpela, N. Lankinen, A. Salminen, T. Suna, P. Soininen, R. Laatikainen, P. Ingman, M. Jauhiainen, M.R. Taskinen, K. Heberger, and K. Kaski The inherent accuracy of H-1 NMR spectroscopy to quantify plasma lipoproteins is subclass dependent Atherosclerosis 190 2007 352 358 (Pubitemid 46074051)
129. L. Le Moyec, P. Valensi, J.C. Charniot, E. Hantz, and J.P. Albertini Serum H-1-nuclear magnetic spectroscopy followed by principal component analysis and hierarchical cluster analysis to demonstrate effects of statins on hyperlipidemic patients NMR in Biomedicine 18 2005 421 429 (Pubitemid 41646183)
130. 1H NMR data from human blood plasma Journal of Magnetic Resonance Part B 106 1995 191 194
131. M. Ala-Korpela, Y. Hiltunen, and J.D. Bell Quantification of biomedical NMR data using artificial neural network analysis: lipoprotein lipid profiles from H-1 NMR data of human plasma NMR in Biomedicine 8 1995 235 244
132. J. Niemi, V.P. Mäkinen, J. Heikkonen, L. Tenkanen, Y. Hiltunen, M.L. Hannuksela, M. Jauhiainen, C. Forsblom, M.R. Taskinen, Y.A. Kesäniemi, M.J. Savolainen, K. Kaski, P.H. Groop, P.T. Kovanen, and M. Ala-Korpela Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs Apo-B and IDL, but not LDL, are associated with mortality in type 1 diabetes Annals of Medicine 41 2009 451 461
133. T.F. Bathen, J. Krane, T. Engan, K.S. Bjerve, and D. Axelson Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis NMR in Biomedicine 13 2000 271 288
134. M. Kristensen, F. Savorani, G. Ravn-Haren, M. Poulsen, J. Markowski, F.H. Larsen, L.O. Dragsted, and S.B. Engelsen NMR and interval PLS as reliable methods for determination of cholesterol in rodent lipoprotein fractions Metabolomics 6 2010 129 136
135. H. Serrai, L. Nadal, G. Leray, B. Leroy, B. Delplanque, and J.D. de Certaines Quantification of plasma lipoprotein fractions by wavelet transform time-domain data processing of the proton nuclear magnetic resonance methylene spectral region NMR in Biomedicine 11 1998 273 280 (Pubitemid 28465191)
136. F. Savorani, M. Kristensen, F.H. Larsen, A. Astrup, and S.B. Engelsen High throughput prediction of chylomicron triglycerides in human plasma by nuclear magnetic resonance and chemometrics Nutrition and Metabolism 7 2010 8
137. 1H NMR spectroscopy data NMR in Biomedicine 11 1998 168 176 (Pubitemid 28364090)
138. T. Kohonen, J. Hynninen, J. Kangas, J. Laaksonen, SOM-PAK: The Self-Organizing Map Program Package. Helsinki University of Technology. < http://www.cis.hut.fi/research/som-research/nnrc-programs.shtml >.
139. T. Kohonen Self-Organizing Maps 1995 Berlin Heidelberg
140. T. Suna, A. Salminen, P. Soininen, R. Laatikainen, P. Ingman, S. Makela, M.J. Savolainen, M.L. Hannuksela, M. Jauhiainen, M.R. Taskinen, K. Kaski, and M. Ala-Korpela H-1 NMR metabonomics of plasma lipoprotein subclasses: elucidation of metabolic clustering by self-organising maps NMR in Biomedicine 20 2007 658 672 (Pubitemid 350120246)
141. S.C. Rumsey, A.F. Stucchi, R.J. Nicolosi, H.N. Ginsberg, R. Ramakrishnan, and R.J. Deckelbaum Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys Journal of Lipid Research 35 1994 1592 1598 (Pubitemid 24291220)
142. T.F. Bathen, T. Engan, J. Krane, and D. Axelson Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD Anticancer Research 20 2000 2393 2408 (Pubitemid 30614443)
143. R.M. Boerner, Application and Improvement of Diffusion Ordered Spectroscopy for the Study of Biophysical Systems: An Investigational Study of Human Blood Plasma, University of North Carolina at North Carolina, 1993.
144. 1H diffusion-edited total-correlation NMR spectroscopy Analytical Chemistry 69 1997 1504 1509
145. B.M. Beckwith-Hall, N.A. Thompson, J.K. Nicholson, J.C. Lindon, and E. Holmes A metabonomic investigation of hepatotoxicity using diffusion-edited H-1 NMR spectroscopy of blood serum Analyst 128 2003 814 818 (Pubitemid 36897867)
146. L.M. Smith, A.D. Maher, O. Cloarec, M. Rantalainen, H. Tang, P. Elliott, J. Stamler, J.C. Lindon, E. Holmes, and J.K. Nicholson Statistical correlation and projection methods for improved information recovery from diffusion-edited NMR spectra of biological samples Analytical Chemistry 79 2007 5682 5689 (Pubitemid 47229815)
147. http://www.lipofit.de/index-engl.html (consulted 24.02.11).
148. E.A. Stein, and G.L. Myers National cholesterol edication program recommentations for triglyceride measurement, executive summary Clinical Chemistry 41 1995 1421 1426
149. P. Linsel-Nitschke, H. Jansen, Z. Aherrarhou, S. Belz, B. Mayer, W. Lieb, F. Huber, W. Kremer, H.R. Kalbitzer, J. Erdmann, and H. Schunkert Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography Lipids in Health and Disease 8 2009
150. M. Ala-Korpela Critical evaluation of (1)H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics Clinical Chemistry and Laboratory Medicine 46 2008 27 42
151. H.M. Colhoun, J.D. Otvos, M.B. Rubens, M.R. Taskinen, S.R. Underwood, and J.H. Fuller Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes Diabetes 51 2002 1949 1956 (Pubitemid 34564310)
152. W.T. Garvey, S. Kwon, D. Zheng, S. Shaughnessy, P. Wallace, A. Hutto, K. Pugh, A.J. Jenkins, R.L. Klein, and Y.L. Liao Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance Diabetes 52 2003 453 462 (Pubitemid 36173203)
153. A. Festa, K. Williams, A.J.G. Hanley, J.D. Otvos, D.C. Goff, L.E. Wagenknecht, and S.M. Haffner Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the insulin resistance atherosclerosis study Circulation 111 2005 3465 3472 (Pubitemid 40923401)
154. A.M. Hodge, A.J. Jenkins, D.R. English, K. O'Dea, and G.G. Giles NMR-determined lipoprotein subclass profile predicts type 2 diabetes Diabetes Research and Clinical Practice 83 2009 132 139
155. S. Mora, J.D. Otvos, R.S. Rosenson, A. Pradhan, J.E. Buring, and P.M. Ridker Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women Diabetes 59 2010 1153 1160
156. S.S. Soedamah-Muthu, H.M. Colhoun, M.J. Thomason, D.J. Betteridge, P.N. Durrington, G.A. Hitman, J.H. Fuller, K. Julier, M.I. Mackness, H.A.W. Neil, and C.I. The The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease Atherosclerosis 167 2003 243 255 (Pubitemid 36773524)
157. R.L. Klein, M.B. McHenry, K.H. Lok, S.J. Hunter, N.A. Le, A.J. Jenkins, D. Zheng, A.J. Semler, W.V. Brown, T.J. Lyons, and W.T. Garvey Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses Metabolism-Clinical and Experimental 53 2004 1296 1304 (Pubitemid 39222090)
158. A.J. Jenkins, T. Lyons, D.Y. Zheng, J.D. Otvos, D.T. Lackland, D. McGee, W.T. Garvey, R.L. Klein, and D.E.R. Grp Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort-associations with gender and glycemia Diabetes Care 26 2003 810 818 (Pubitemid 36929348)
159. T.J. Lyons, A.J. Jenkins, D.Y. Zheng, D.T. Lackland, D. McGee, W.T. Garvey, R.L. Klein, and D.E.R. Grp Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort Investigative Ophthalmology and Visual Science 45 2004 910 918 (Pubitemid 38868391)
160. A.J. Kreis, T.Y. Wong, F.M.A. Islam, R. Klein, B.E.K. Klein, M.F. Cotch, A.J. Jenkins, S. Shea, and J.J. Wang Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The multi-ethnic study of atherosclerosis (MESA) Diabetes and Vascular Disease Research 6 2009 40 42
161. V.P. Makinen, P. Soininen, C. Forsblom, M. Parkkonen, P. Ingman, K. Kaski, P.H. Groop, M. Ala-Korpela, and G. FinnDiane Study Diagnosing diabetic nephropathy by H-1 NMR metabonomics of serum Magnetic Resonance Materials in Physics Biology and Medicine 19 2006 281 296 (Pubitemid 47394323)
162. B. Valcárcel, P. Würtz, N.K.S. al Basatena, T. Tukiainen, A.J. Kangas, P. Soininen, M.R. Järvelin, M. Ala-Korpela, T.M. Ebbels, and M. de Iorio A differential network approach to exploring differences between biological states: an application to prediabetes PLoS ONE 6 2011 e24702
163. V.P. Mäkinen, T. Tynkkynen, P. Soininen, C. Forsblom, T. Peltola, A.J. Kangas, P.H. Groop, and M. Ala-Korpela Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study) Metabolomics 8 2011 1 7
164. P. Soininen, A.J. Kangas, P. Würtz, T. Tukiainen, T. Tynkkynen, R. Laatikainen, M.R. Järvelin, M. Kähönen, T. Lehtimäki, J. Viikari, O.T. Raitakari, M.J. Savolainen, and M. Ala-Korpela High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism Analyst 134 2009 1781 1785
165. 1H-nuclear magnetic spectroscopy followed by principal component analysis and hierarchical cluster analysis to demonstrate effects of statins on hyperlipidemic patients NMR in Biomedicine 18 2005 421 429 (Pubitemid 41646183)
166. 1H NMR-determined diffusion coefficients to characterize lipoprotein fractions in human blood plasma Magnetic Resonance in Chemistry 40 2002 S83-S88
167. M. Dyrby, M. Petersen, A.K. Whittaker, L. Lambert, L. Nørgaard, R. Bro, and S.B. Engelsen Analysis of lipoproteins using 2D diffusion-edited NMR spectroscopy and multi-way chemometrics Analytica Chimica Acta 531 2005 209 216 (Pubitemid 40255156)
168. S.S. Soedamah-Muthu, H.M. Colhoun, M.J. Thomason, D.J. Betteridge, P.N. Durrington, G.A. Hitman, J.H. Fuller, K. Julier, M.I. Mackness, and H.A.W. Neil The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease Atherosclerosis 167 2003 243 255 (Pubitemid 36773524)